Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jorge Arca-Suárez

23PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Microbial geneticsMedical infection agents (incl. prions)Medical bacteriologyMycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

Sort by Publication Date:
|May 29, 2026
Comparative activity of ceftibuten combinations with avibactam, ledaborbactam, and xeruborbactam against recombinant β-lactamase-producing <i>Escherichia coli</i> and contemporary WGS-characterized strains of carbapenemase-producing Enterobacterales.

|May 29, 2026
Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in <i>Pseudomonas aeruginosa</i>.

|Mar 27, 2026
Emergence of KPC-producing <i>Pseudomonas aeruginosa</i> in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam.

Gloria Pérez-Rodríguez, Pablo Aja-Macaya, Lucía González-Pinto

|Feb 19, 2026
Disarming carbapenemase-producing <i>Acinetobacter baumannii</i>: high potency of the novel therapeutic combination of meropenem and the innovative diazabicyclooctane β-lactamase inhibitor pilabactam (formerly ANT3310).

Salud Rodríguez-Pallares, Michelle Outeda-García, Emilio Lence

|Dec 22, 2025
Antibacterial activity of enmetazobactam against <i>Acinetobacter</i> spp.: a molecular dissection of mechanism of action and resistance determinants.

Gabriela-Alejandra Báez-Barroso, Arianna Rodríguez-Coello, Juan Carlos Vázquez-Ucha

|Oct 21, 2025
Contribution of mutational resistance mechanisms and acquired β-lactamases to cefiderocol/xeruborbactam susceptibility in <i>Pseudomonas aeruginosa</i>.

Lucía González-Pinto, María Antonia Gomis-Font, Gloria Pérez-Rodríguez

Pageof 4

Frequent Collaborators

21 joint publications

Alejandro Beceiro

17 joint publications

Germán Bou

12 joint publications

Lucía González-Pinto

11 joint publications

Tania Blanco-Martín

9 joint publications

Juan Carlos Vázquez-Ucha

9 joint publications

Salud Rodríguez-Pallares

7 joint publications

Michelle Outeda-García

7 joint publications

Antonio Oliver

6 joint publications

Lucía Sánchez-Peña

5 joint publications

Gloria Pérez-Rodríguez

Frequent Collaborators

21 joint publications

Alejandro Beceiro

17 joint publications

Germán Bou

12 joint publications

Lucía González-Pinto

11 joint publications

Tania Blanco-Martín